,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['panitumumab', 'breast']
we should seriously consider the panitumumab-dxd. certainly it would be a success #asco22. impressive results for destiny-breast-04 
??????????? ??? ????????. Passionate and perfectionist. Med Onc with special love to Gyn Onc and prostate cancer.